ANI Pharmaceuticals Inc
Ownership
Ownership Structure
Who owns ANI Pharmaceuticals Inc (ANIP)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 85.6% of the shares are freely tradable; institutional investors hold 110.4%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 11.96 | 2,747,492 | +3.2 | 03/31/2026 |
| Soleus Capital Management, L.P. | 3.78 | 867,760 | +5.8 | 06/30/2026 |
| Vanguard Capital Management, LLC | 3.58 | 823,064 | +0.0 | 03/31/2026 |
| State Street Corp | 3.36 | 771,587 | +6.1 | 03/31/2026 |
| TANG CAPITAL MANAGEMENT LLC | 3.08 | 707,500 | +47.0 | 03/31/2026 |
| Dimensional Fund Advisors, Inc. | 2.71 | 623,463 | +17.4 | 06/30/2026 |
| American Century Companies Inc | 2.50 | 574,474 | +199.9 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 4.84 | 1,110,724 | +0.0 | 08/31/2026 |
| Avantis US Small Cap Value ETF | 2.81 | 645,686 | +0.3 | 08/31/2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 2.68 | 614,623 | +0.9 | 07/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Lalwani Nikhil | PRESIDENT & CEO | 339,089 | 25,567,311 $ | Sep 15, 2026 | direct |
| Carey Stephen P. | SVP & CFO | 171,843 | 12,956,962 $ | Aug 31, 2026 | direct |
| Gutwerg Ori | SVP, GENERICS | 75,534 | 5,695,264 $ | Aug 10, 2026 | direct |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 73,924 | 5,573,870 $ | Sep 14, 2026 | direct |
| Thoma Jeanne | Director | 26,762 | 2,017,855 $ | Sep 11, 2026 | direct |
| Gosebruch Henry O | Director | 6,662 | 502,315 $ | Aug 19, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | Lalwani Nikhil | PRESIDENT & CEO | Sell | 5,400 | 71.00 | 383,400 |
| Sep 14, 2026 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | Sell | 500 | 70.79 | 35,395 |
| Sep 11, 2026 | Thoma Jeanne | Director | Sell | 1,000 | 71.53 | 71,530 |
| Aug 31, 2026 | Carey Stephen P. | SVP & CFO | Sell | 2,850 | 72.80 | 207,480 |
| Aug 25, 2026 | Lalwani Nikhil | PRESIDENT & CEO | Sell | 5,400 | 74.30 | 401,220 |
| Aug 19, 2026 | Gosebruch Henry O | Director | Other | 6,662 | 0.00 | – |
| Aug 13, 2026 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | Sell | 500 | 75.48 | 37,740 |
| Aug 10, 2026 | Gutwerg Ori | SVP, GENERICS | Sell | 3,162 | 77.00 | 243,474 |
| Jul 29, 2026 | Carey Stephen P. | SVP & CFO | Sell | 2,850 | 81.36 | 231,876 |
| Jul 18, 2026 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | Other | 2,466 | 79.20 | 195,307 |
| Jul 13, 2026 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | Sell | 500 | 81.84 | 40,920 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.